Influenza Journal Articles

• Nirsevimab for Preventing RSV in Infants and Young Children The Advisory Committee on Immunization Practices reviewed the safety and efficacy of nirsevimab for preventing RSV among patients of this age group and provides recommendations for its use.
  Morbidity & Mortality Weekly Report, November 03, 2023
• Vaccination Coverage Among Adolescents Aged 13-17 Years National vaccination coverage rates for this age group have declined in recent years. How can we ensure these adolescents get up-to-date?
  Morbidity & Mortality Weekly Report, November 01, 2023
• Effectiveness of COVID-19 mRNA Vaccines in Young Children This report presents postauthorization vaccine effectiveness data for monovalent and bivalent COVID-19 mRNA vaccines in young children.
  Morbidity & Mortality Weekly Report, October 25, 2023
• Measles Outbreak -- Central Ohio, 2022-2023 This CDC report reveals that over 90 percent of children infected in a recent measles outbreak in Ohio had not received the MMR vaccine.
  Morbidity & Mortality Weekly Report, October 13, 2023
• Use of Respiratory Syncytial Virus Vaccines in Older Adults While RSV is usually associated with young children, it can also cause severe respiratory illness in older adults. This report reviews ACIP recommendations for RSV vaccine in adults over 60.
  Morbidity & Mortality Weekly Report, October 02, 2023
• Effect of Norovirus Dose on Virus Shedding and Symptoms How do different doses of norovirus inoculum impact virus shedding and time to symptom onset?
  Emerging Infectious Diseases, September 26, 2023
• Respiratory Virus Testing Among School Students and Staff This study found that 25% of primary and secondary school students and staff members of a large metropolitan school district tested positive for at least one respiratory virus.
  Morbidity & Mortality Weekly Report, September 25, 2023
• Pemphigus Vulgaris After the Second Dose of COVID-19 Vaccine This report details a case of new-onset pemphigus vulgaris, a potentially severe autoimmune blistering disease, after a series of COVID-19 vaccinations.
  Journal of Medical Case Reports, September 15, 2023
• Early Empiric Antibiotics in Hospitalized COVID-19 Patients How often are hospitalized COVID-19 patients treated with empiric antibiotics? Are they being used appropriately? This study looked at the prescribing trends.
  Critical Care Medicine, September 08, 2023
• Kikuchi-Fujimoto Disease Following COVID-19 Vaccination How common is Kikuchi-Fujimoto disease, or histiocytic necrotizing lymphadenitis, following COVID-19 vaccination? Is there a causal relationship?
  American Journal of Clinical Pathology, August 25, 2023
• Risk for Human H5N1 Virus After Exposure to Infected Birds How likely is one to develop H5N1 virus infection after being exposed to infected birds? This report provides some insight.
  Emerging Infectious Diseases, August 22, 2023
• Update on Pediatric Intracranial Infections The U.S. saw a large increase in brain abscesses in children in winter 2022-2023 following a surge in respiratory infections, but these abscesses still remain rare, according to this CDC report.
  Morbidity & Mortality Weekly Report, August 14, 2023
• Urticaria After SARS-CoV2 in a Triple-vaccinated Patient This case report describes the cutaneous effects of a SARS-CoV2 Omicron BA.5 variant breakthrough infection in a triple-vaccinated patient.
  Journal of Medical Case Reports, August 11, 2023
• Probable SARS-CoV-2 Transmission From Lion to Zoo Employees This report highlights the potential for the zoonotic transmission of SARS-CoV-2 between zoo animals and humans.
  Emerging Infectious Diseases, August 10, 2023
• Bivalent mRNA Vaccine Durability in Preventing Severe Disease How long does the bivalent COVID-19 booster offer protection against COVID-19-associated hospitalization and severe illness?
  Morbidity & Mortality Weekly Report, August 07, 2023
• Effectiveness and Safety of SARS-CoV-2 Vaccination in HIV A systematic review and meta-analysis looks at the immune, efficacy, and safety outcomes of the SARS-CoV-2 vaccine among people with HIV compared with people without HIV.
  AIDS, July 20, 2023
• Effectiveness of Monovalent mRNA COVID-19 Vaccine During Omicron This report shows that monovalent mRNA COVID-19 vaccines continued to provide substantial protection against COVID-19-associated IMV and death, even during the period of the Omicron variant.
  Morbidity & Mortality Weekly Report, July 07, 2023
• Neuropsychiatric Disorders Following SARS-CoV-2 Infection This review examines the neuropsychiatric consequences of COVID-19 infection. What factors may influence the risk of post-COVID neuropsychiatric disorders? Does vaccination ameliorate the risk?
  Brain, June 27, 2023
• COVID-19 Risk by Workers' Occupation and Industry in the U.S. Does work in specific occupations and industries pose a heightened risk for COVID-19?
  American Journal of Public Health, June 19, 2023
• Genomic Characterization of RSV During 2022-23 Outbreak Genomic surveillance provides insight into the RSV strains involved in a recent outbreak.
  Emerging Infectious Diseases, June 15, 2023